These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19874862)

  • 1. Targeted delivery of low molecular drugs using chitosan and its derivatives.
    Park JH; Saravanakumar G; Kim K; Kwon IC
    Adv Drug Deliv Rev; 2010 Jan; 62(1):28-41. PubMed ID: 19874862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan mediated targeted drug delivery system: a review.
    Patel MP; Patel RR; Patel JK
    J Pharm Pharm Sci; 2010; 13(4):536-57. PubMed ID: 21486530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery.
    Chopra S; Mahdi S; Kaur J; Iqbal Z; Talegaonkar S; Ahmad FJ
    J Pharm Pharmacol; 2006 Aug; 58(8):1021-32. PubMed ID: 16872548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan-based delivery systems for protein therapeutics and antigens.
    Amidi M; Mastrobattista E; Jiskoot W; Hennink WE
    Adv Drug Deliv Rev; 2010 Jan; 62(1):59-82. PubMed ID: 19925837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based hydrogels for controlled, localized drug delivery.
    Bhattarai N; Gunn J; Zhang M
    Adv Drug Deliv Rev; 2010 Jan; 62(1):83-99. PubMed ID: 19799949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs.
    van der Merwe SM; Verhoef JC; Verheijden JH; Kotzé AF; Junginger HE
    Eur J Pharm Biopharm; 2004 Sep; 58(2):225-35. PubMed ID: 15296951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan and its salts for mucosal and transmucosal delivery.
    Bonferoni MC; Sandri G; Rossi S; Ferrari F; Caramella C
    Expert Opin Drug Deliv; 2009 Sep; 6(9):923-39. PubMed ID: 19637983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
    Agnihotri SA; Mallikarjuna NN; Aminabhavi TM
    J Control Release; 2004 Nov; 100(1):5-28. PubMed ID: 15491807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.
    Luppi B; Bigucci F; Cerchiara T; Zecchi V
    Expert Opin Drug Deliv; 2010 Jul; 7(7):811-28. PubMed ID: 20560778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
    Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
    J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review paper: chitosan derivatives as promising materials for controlled drug delivery.
    Prabaharan M
    J Biomater Appl; 2008 Jul; 23(1):5-36. PubMed ID: 18593819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan derivatives obtained by chemical modifications for biomedical and environmental applications.
    Alves NM; Mano JF
    Int J Biol Macromol; 2008 Dec; 43(5):401-14. PubMed ID: 18838086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical, pharmaceutical and biological approaches toward designing optimized and efficient hydrophobically modified chitosan-based polymeric micelles as a nanocarrier system for targeted delivery of anticancer drugs.
    Mahmoudzadeh M; Fassihi A; Emami J; Davies NM; Dorkoosh F
    J Drug Target; 2013 Sep; 21(8):693-709. PubMed ID: 23915108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
    George M; Abraham TE
    J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembled nanoparticles containing hydrophobically modified glycol chitosan for gene delivery.
    Yoo HS; Lee JE; Chung H; Kwon IC; Jeong SY
    J Control Release; 2005 Mar; 103(1):235-43. PubMed ID: 15710514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-based formulations for delivery of DNA and siRNA.
    Mao S; Sun W; Kissel T
    Adv Drug Deliv Rev; 2010 Jan; 62(1):12-27. PubMed ID: 19796660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.
    Mannila J; Järvinen K; Holappa J; Matilainen L; Auriola S; Jarho P
    Int J Pharm; 2009 Oct; 381(1):19-24. PubMed ID: 19632311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles.
    Wang J; Tao X; Zhang Y; Wei D; Ren Y
    Biomaterials; 2010 May; 31(15):4426-33. PubMed ID: 20188412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.